Stoke Therapeutics's total assets for Q1 2026 were $443.28M, an increase of 5.94% from the previous quarter. STOK total liabilities were $48.40M for the fiscal quarter, a -26.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.